The Valley Desk

NCT06132035 · Interventional trial

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Overall registry status Recruiting

Phase 1

Conditions Age-related Wet Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov